Navigation Links
GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
Date:11/12/2007

LARGO, Fla., Nov. 12 /PRNewswire-FirstCall/ -- GeoPharma, Inc. (Nasdaq: GORX) (the "Company") GeoPharma, Inc. announced today it has received an approval from the FDA to begin producing Carprofen.

Commonly marketed by Pfizer as Rimadyl(TM), Carprofen is a non-steroidal anti-inflammatory drug (NSAID) that is used by veterinarians for the relief of pain and inflammation associated with osteoarthritis in dogs. Additionally, Carprofen is often used in the treatment of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.

"This is a major step forward in the company's tactical plans to offer generic drugs," stated GeoPharma CEO Mihir K. Taneja. "We are tremendously pleased to have received final approval on Carprofen from the FDA for both the company and our shareholders. GeoPharma has anticipated this approval and is well prepared to have its arrival begin to translate into sales and net income almost immediately. This is the first of what we anticipate will be many approvals for GeoPharma. We continue to be enthusiastic about our drug pipeline which holds 12 ANDAs and other drug products in various stages of development and the approval process. It is our hope to receive additional approvals by the end of our fiscal year on other drugs, as well as a production approval of our dedicated 100,000 Sq. Ft. Beta Lactam manufacturing facility located in Baltimore, Maryland," added Mr. Taneja.

The company detailed its plans to produce Carprofen in three strengths 25 mg, 75 mg, and 100 mg caplets, allowing for appropriate dosing and cost effective pain management for the animals. Furthermore, the company reiterated its strategic commitment to aggressively pursue attractive generic drug and medical device opportunities wherever they present themselves.

About GeoPharma Inc: GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the- counter, nutritional, gener
'/>"/>

SOURCE GeoPharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., Whether it,s CD packaging, containers or ident...fication) are increasingly finding their way into ...cts or goods and identify them automatically by ra...d process the data contained in the label. Smart l...ditions of up to 100 degrees Celsius. But at highe...
(Date:11/24/2009)...wswire-FirstCall/--DowAgroSciencesCanadaannouncedt...fThompsonsLimitedofBlenheim,Ontario.TheadditionofH...seedsbusinessasthecompanyanticipatestheintroductio...icideTolerantTraitTechnologyincornin2012.Thetransa...acquisitionbringstogethertwostrongprogressivecompa...
(Date:11/24/2009)...harmaceuticalsInc.announced,theUSPatent&Tradem...snano-particleoraldeliveryorNODtechnology. , ...tepeptidesor,proteinsintobio-adhesivenano-particle...asinjections.NODtechnologyisaplatformtechnology,th...in,interferon,growthhormone,exenatide,heparinandm...
(Date:11/24/2009)...tientswithadvanced-stage,orrecurrentendometrialcan.../-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the"C...ndocrinetherapyandoncology,todayannouncedpositivee...cpeptideconjugate,AEZS-108(formerlyAN-152),inpatie...sonalizedhealthcareapproach,thestudyselectedpatien...
Breaking Biology Technology:Intelligence inside metal components 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
... Medivation, Inc.,(Nasdaq: MDVN ) presented new ..., its lead product candidate in development to tre...lly operates via a novel mitochondrial,mechanism o...n to impact two,key aspects of brain cell function...itochondrial function after brain cells were chall...
... EntreMed, Inc.,(Nasdaq: ENMD ), a clinical-sta...for the treatment of cancer and inflammatory disea... 1 study of ENMD-2076 in refractory,multiple myelo...ndiana,University Melvin and Bren Simon Cancer Ce...ociate Professor, Department of Medicine, will ser...
...ec. 8 Align Technology,Inc. (Nasdaq: ALGN ) tod...val,from the Japanese Ministry of Health, Labour a...spread marketing and promotion of Invisalign in Ja...lign orthodontists since launching the,product the...oval in Japan is an important milestone and will,e...
Other Biology Technology:Medivation Presents New Data on Dimebon's Novel Mechanism of Action 2Medivation Presents New Data on Dimebon's Novel Mechanism of Action 3Medivation Presents New Data on Dimebon's Novel Mechanism of Action 4EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 2EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 3EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma 4Align Technology Receives Expanded Regulatory Approval in Japan 2
(Date:11/24/2009)...atter of debate. A high-profile study a few years ...heir carbon from trees and leaves, evidence for a ...c ecosystems. , But new research from the Univer...true. Algae provide a much richer diet for fish an...hed this week in the Proceedings of the National ...
(Date:11/23/2009)...rong evidence that the "synergistic" effect of ear...ollution and indoor endotoxin causes more harm to ...one. , Environmental health scientists at the ...have shown that children exposed to both high leve...in during early life are six times more likely to ...
(Date:11/23/2009)... time of day matters to forest trees dealing with ...search team led by Professor Malcolm Campbell, Uni...r research and colleagues in the department of cel..., Capitalizing on their previous work to decode ...xamined how poplar trees use their 45,000 genes to...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Feed the Mind 3A Brain Metrix Experiences Tremendous Growth with Popularity of Brain Fitness Games 61758 1Feed the Mind 3A Brain Metrix Experiences Tremendous Growth with Popularity of Brain Fitness Games 61758 2Feed the Mind 3A Brain Metrix Experiences Tremendous Growth with Popularity of Brain Fitness Games 61758 3First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 1First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 2First Time Father to Be Quits Smoking Wins 245 000 in The QuitCash Challenge 28TM 29 61753 3U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 1U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 2
... enigma unique to flowering plants has been solv... (UK) and POSTECH, South Korea. , The discovery i...008. , Scientists already knew that flowering pla... cells for successful fertilisation. , The myster...ach single pollen grain could produce ,twin, sperm...
...EGE PARK, Md. Maryland officials can reduce elect... revenues from the Regional Greenhouse Gas Initiat...ency programs, says a new study from a University ...oring states might benefit as well. , Investments...rs or businesses buy more energy-efficient applian...
...earchers at National Jewish Health are testing an ... in the lungs of emphysema patients can immediatel...ng tissue caused by emphysema can leave lungs stif...e holes, kept open by small stents inserted during... hyperinflation of the lungs, allowing the healthy...
Other Biology News:Biologists discover gene behind 'plant sex mystery' 2Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 2Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 3Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 4Greenhouse gas auction revenues can help cut Md. electric use significantly, says study 5Researchers at National Jewish Health evaluating a treatment 2
Anti-Tubulin-acetylated Monoclonal Antibody, Unconjugated, Clone 6-11b-1 from Invitrogen
Mouse Anti-Thyroid Hormone Receptor beta 1 Monoclonal Antibody, Unconjugated, Clone J53 from Abcam
Rabbit Anti-Human TRIB1 / SKIP1 / Tribbles 1 Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human Myeloid Marker Monoclonal Antibody, Unconjugated, Clone BM-1 from Santa Cruz Biotechnology, Inc.
Biology Products: